These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6722181)

  • 41. Evaluation of a purification procedure for the muscarinic receptor for the purpose of quantitative receptor assays of anticholinergics. Part A: The membrane-bound receptor.
    Smisterová J; Ensing K; de Zeeuw RA
    Prep Biochem; 1995 Nov; 25(4):197-221. PubMed ID: 8570569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
    Aguilar JS; Salas PJ; De Robertis E
    Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
    [No Abstract]   [Full Text] [Related]  

  • 43. Charge but not chemical class explains the selective binding of [3H]N-methylscopolamine to a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat cerebral cortex homogenates.
    Lee NH; Ramkumar V; el-Fakahany EE
    Eur J Pharmacol; 1986 Oct; 130(1-2):153-5. PubMed ID: 3780857
    [No Abstract]   [Full Text] [Related]  

  • 44. A muscarinic receptor type in human lymphocytes: a comparison of 3H-QNB binding to intact lymphocytes and lysed lymphocyte membranes.
    Adem A; Nordberg A; Slanina P
    Life Sci; 1986 Apr; 38(15):1359-68. PubMed ID: 3959757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for muscarinic receptors on rat colonic epithelial cells: binding of [3H]quinuclidinyl benzilate.
    Rimele TJ; O'Dorisio MS; Gaginella TS
    J Pharmacol Exp Ther; 1981 Aug; 218(2):426-34. PubMed ID: 7252842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific [3H]-N-methyl scopolamine binding without cholinergic function in cultured adult skin fibroblasts.
    Kelsoe JR; Gillin JC; Janowsky DS; Brown JH; Risch SC; Lumkin B
    Life Sci; 1986 Apr; 38(15):1399-408. PubMed ID: 3007910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased binding of the muscarinic antagonist [3H]N-methylscopolamine in mouse brain following acute treatment with an organophosphate.
    Cioffi CL; el-Fakahany EE
    Eur J Pharmacol; 1986 Dec; 132(2-3):147-54. PubMed ID: 3816972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [3H]N-Methylscopolamine binding to muscarinic receptors in intact adult rat brain cell aggregates.
    Lee JH; el-Fakahany EE
    Biochem Pharmacol; 1985 Dec; 34(24):4299-303. PubMed ID: 4074390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Agonist-induced muscarinic cholinergic receptor internalization, recycling and degradation in cultured neuronal cells. Cellular mechanisms and role in desensitization.
    Maloteaux JM; Hermans E
    Biochem Pharmacol; 1994 Jan; 47(1):77-88. PubMed ID: 8311846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-binding relationship of quinuclidinyl benzilate analogs on N4TG1 neuroblastoma muscarinic receptors.
    Chang YF
    Neurochem Res; 1988 May; 13(5):455-62. PubMed ID: 3405371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of paraoxon and sulfhydryl reagents on the binding of 3H-quinuclidinyl benzilate and 3H-methylscopolamine with synaptic membranes of rat cerebral cortex].
    Golovko AI; Sofronov GA; Kurganova TA; Kliuntina TV
    Biull Eksp Biol Med; 1994 Jul; 118(7):51-3. PubMed ID: 7919274
    [No Abstract]   [Full Text] [Related]  

  • 53. [3H]quinuclidinyl benzilate binding to the human lung muscarinic receptor.
    Joad JP; Casale TB
    Biochem Pharmacol; 1988 Mar; 37(5):973-6. PubMed ID: 3345208
    [No Abstract]   [Full Text] [Related]  

  • 54. Inhibition of [3H]dexetimide binding by a homologous series of methylfurthrethonium analogues at the peripheral muscarinic receptor.
    Beld AJ; Klok EJ; Rodrigues de Miranda JF
    Biochem Biophys Res Commun; 1980 Nov; 97(2):430-6. PubMed ID: 7470106
    [No Abstract]   [Full Text] [Related]  

  • 55. Muscarinic receptors and responses in intact embryonic chick atrial and ventricular heart cells.
    Siegel RE; Fischbach GD
    Dev Biol; 1984 Feb; 101(2):346-56. PubMed ID: 6692983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gallamine exerts biphasic allosteric effects at muscarinic receptors.
    Ellis J; Seidenberg M
    Mol Pharmacol; 1989 Feb; 35(2):173-6. PubMed ID: 2918854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [3H]-Quinuclidinyl benzilate binding to muscarinic receptors in rat brain: comparison of results from intact brain slices and homogenates.
    Gilbert RF; Hanley MR; Iversen LL
    Br J Pharmacol; 1979 Mar; 65(3):451-6. PubMed ID: 427318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [3H]QNB binding to muscarinic receptors in intact avian salt gland cells.
    Hootman SR; Ernst SA
    Am J Physiol; 1982 Nov; 243(5):C254-61. PubMed ID: 7137336
    [No Abstract]   [Full Text] [Related]  

  • 59. Ligand-binding propeties of the muscarinic acetylcholine receptor in mouse neuroblastoma cells.
    Strange PG; Birdsall NJ; Burgen AS
    Biochem J; 1978 Jun; 172(3):495-501. PubMed ID: 567477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
    J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.